The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats
Author:
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2008.01760.x/fullpdf
Reference35 articles.
1. 1. Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004; 1: 98-105.
2. 2. Brenner DA , Waterboer T , Choi SK , et al. New aspects of hepatic fibrosis. J Hepatol 2000; 32 (Suppl.): 32-8.
3. 3. Endoh T , Tang Q , Denda A , et al. Inhibition by acetylsalicylic acid, a cyclo-oxygenase inhibitor, and p-bromophenacylbromide, a phospholipase A2 inhibitor, of both cirrhosis and enzyme-altered nodules caused by a choline-deficient, l-amino acid defined diet in rats. Carcinogenesis 1996; 17: 467-75.
4. 4. Clària J , Arroyo V. Prostaglandins and other cyclooxygenase-dependent arachidonic acid metabolites and the kidney in liver disease. Prostaglandins Other Lipid Mediat 2003; 72: 19-33.
5. 5. Bosch-Marce M , Claria J , Titos E , et al. Selective inhibition of cyclooxygenase-2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. Gastroenterology 1999; 116: 1167-75.
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl4-Induced Liver Fibrosis in Rats;Antioxidants;2023-03-03
2. New Advances in the Treatment of Portal Hypertension and Its Complications in Cirrhosis;Advances in Clinical Medicine;2022
3. Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress;Journal of Cellular and Molecular Medicine;2021-10-05
4. Role of eicosanoids in liver repair, regeneration and cancer;Biochemical Pharmacology;2021-10
5. Anti‑inflammation treatment for protection of hepatocytes and amelioration of hepatic fibrosis in rats;Experimental and Therapeutic Medicine;2021-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3